Cboe, CME And ICE Are Facing A Perpetual Futures Margin Test
TL;DR: The CFTC's May 29 approval of KalshiEX's bitcoin perpetual futures contract pulled a formerly offshore crypto trading format into the U.S. regulated derivatives stack. That matters because investors immediately treated it as a market-structure threat to Cboe Global Markets, CME Group, and Intercontinental Exchange. The sharper point is not that perpetual futures will replace institutional hedging. It is that retail derivatives revenue may get repriced around faster, simpler, always-on speculation. #What The CFTC Actually Opened The CFTC approved KalshiEX's BTCPERP contract on May 29, 2026, as a futures contract referencing the spot price of bitcoin. The agency also issued a policy statement on perpetual contracts, saying other asset classes should be reviewed case by case. That last phrase is doing the work. This is not a blanket approval for every perpetual product on every market. But it gives U.S. venues a legal and operational path for a product style that crypto traders already understand: no normal expiration date, funding mechanics instead of contract rolls, and a trading rhythm built for short holding periods. Why this is bigger than a bitcoin product The first approval was bitcoin. The investor reaction was about equities, commodities, and retail trading habits. Reuters reported that Cboe fell 9% while CME Group and Intercontinental Exchange each fell roughly 4% as traders worried perpetual futures could spread beyond crypto. That is the useful signal. Exchange stocks were not being marked down because one bitcoin contract exists. They were being marked down because a high-margin product map suddenly looked less settled. #Why Exchange Investors Reacted So Hard Traditional exchange businesses are often treated like toll roads. Products have network effects. Liquidity attracts more liquidity. Clearing relationships, risk controls, and institutional workflows make the moat feel borin



